MEDIXPO: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDIXPO
Largest movements
- Receivables within one year -€5,022
down €5,022 (-68.1%), from €7,371 to €2,349
of which Trade receivables: -€4,430
- Tangible fixed assets +€2,100
up €2,100 (+63.2%), from €3,325 to €5,425
- Cash +€319
up €319 (+16,088%), from €2 to €321
mainly Receivables within one year (+€5,022) and Tax, wage and social debts (+€4,971)
- Other debts -€7,087
down €7,087 (-85.1%), from €8,331 to €1,244
- Tax, wage and social debts +€4,971
new in 2025: €4,971
- Trade debts -€3,138
down €3,138 (-86.2%), from €3,642 to €504
- Profit (loss) carried forward +€1,350
up €1,350 (+7.0%), from -€19,275 to -€17,925
- Contributions +€1,300
up €1,300 (+7.2%), from €18,000 to €19,300
- Turnover +€42,295
new in 2025: €42,295
- Purchases and services +€31,211
up €31,211 (+459%), from €6,805 to €38,016
- Gross operating margin +€11,129
up €11,129, from -€6,805 to €4,324
- Depreciation +€2,425
up €2,425 (+511%), from €475 to €2,900
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €10,698 | €8,095 | -€2,603 | -24.3% |
| Fixed assets | 21/28 | €3,325 | €5,425 | +€2,100 | +63.2% |
| Tangible fixed assets | 22/27 | €3,325 | €5,425 | +€2,100 | +63.2% |
| Furniture and vehicles | 24 | €3,325 | €5,425 | +€2,100 | +63.2% |
| Current assets | 29/58 | €7,373 | €2,670 | -€4,703 | -63.8% |
| Amounts receivable within one year | 40/41 | €7,371 | €2,349 | -€5,022 | -68.1% |
| Trade receivables | 40 | €6,779 | €2,349 | -€4,430 | -65.4% |
| Other amounts receivable | 41 | €591 | - | -€591 | |
| Cash at bank and in hand | 54/58 | €2 | €321 | +€319 | +16,088% |
| Total equity and liabilities | 10/49 | €10,698 | €8,095 | -€2,603 | -24.3% |
| Equity | 10/15 | -€1,275 | €1,375 | +€2,650 | |
| Contributions | 10/11 | €18,000 | €19,300 | +€1,300 | +7.2% |
| Profit (loss) carried forward | 14 | -€19,275 | -€17,925 | +€1,350 | +7.0% |
| Amounts payable | 17/49 | €11,973 | €6,719 | -€5,254 | -43.9% |
| Amounts payable within one year | 42/48 | €11,973 | €6,719 | -€5,254 | -43.9% |
| Trade debts | 44 | €3,642 | €504 | -€3,138 | -86.2% |
| Suppliers | 440/4 | €3,642 | €504 | -€3,138 | -86.2% |
| Taxes, remuneration and social security | 45 | - | €4,971 | +€4,971 | |
| Taxes | 450/3 | - | €4,971 | +€4,971 | |
| Other amounts payable | 47/48 | €8,331 | €1,244 | -€7,087 | -85.1% |
| Turnover | 70 | - | €42,295 | +€42,295 | |
| Goods, raw materials, services and sundry goods | 60/61 | €6,805 | €38,016 | +€31,211 | +459% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €475 | €2,900 | +€2,425 | +511% |
| Gross operating margin | 9900 | -€6,805 | €4,324 | +€11,129 | |
| Operating profit (loss) | 9901 | -€7,280 | €1,424 | +€8,704 | |
| Financial charges | 65/66B | €251 | €74 | -€178 | -70.6% |
| Recurring financial charges | 65 | €251 | €74 | -€178 | -70.6% |
| Profit (loss) for the period before taxes | 9903 | -€7,531 | €1,350 | +€8,882 | |
| Profit (loss) for the period | 9904 | -€7,531 | €1,350 | +€8,882 | |
| Profit (loss) for the period to be appropriated | 9905 | -€7,531 | €1,350 | +€8,882 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.